J.M. Sánchez‐Tapias

Delayed Clearance of Serum HBsAg in Compensated Cirrhosis B: Relation to Interferon Alpha Therapy and Disease Prognosis

Giovanna Fattovich, G. Giustina, J.M. Sánchez‐Tapias et al. · The American Journal of Gastroenterology · 1998 · 174 citations

Medicine, Internal Medicine, Hepatic Pharmacotherapy +16

Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients†

Montserrat Laguno, Javier Murillas, Sergio Veloso et al. · Hepatology · 2008 · 111 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The Prognostic Relevance of the Nonstructural 5A Gene Interferon Sensitivity Determining Region Is Different in Infections with Genotype 1b and 3a Isolates of Hepatitis C Virus

Juan‐Carlos Sáiz, F. Xavier López‐Labrador, Sergi Ampurdanés et al. · The Journal of Infectious Diseases · 1998 · 106 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Relationship of the Genomic Complexity of Hepatitis C Virus With Liver Disease Severity and Response to Interferon in Patients With Chronic Hcv Genotype 1B Interferon

F. Xavier López‐Labrador, Sergi Ampurdanés, Mireia Giménez‐Barcons et al. · Hepatology · 1999 · 77 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

Conrado Fernández‐Rodríguez, Sonia Alonso Sáenz De Oger, Stella Maris Martínez et al. · The American Journal of Gastroenterology · 2010 · 75 citations

Medicine, Pharmacology, Pharmacotherapy +17